NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/01/2024
Back to search
Official data from USPTO
M ET P
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
02/01/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
10/02/2007
Registration date
07/15/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2015
Last transaction
11/18/2018
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
98
Owner location
CH
Examiner
HAYES, GINA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M&P Pharma AG
C. A. (pessoa física)
Representatives
LAWRENCE E. ABELMAN ABELMAN FRAYNE & SCHWAB
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for the treatment of depressionParkinson's diseasestroke and Alzheimer's disease as well as for hormone replacement therapy
Class 42
Medical laboratories; DNA analysis services
Publications
History of USPTO decisions and trademark events.
34 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/12/2018
RFNT
REFUSAL PROCESSED BY IB
02/16/2018
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/04/2016
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/11/2015
INPC
INVALIDATION PROCESSED
12/11/2015
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/20/2015
CHLD
CHANGE OF OWNER RECEIVED FROM IB
09/03/2015
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
04/15/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/03/2015
C71T
CANCELLED SECTION 71
02/20/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/07/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/06/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/04/2008
FIMP
FINAL DISPOSITION PROCESSED
11/04/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/16/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
07/15/2008
PUBO
PUBLISHED FOR OPPOSITION
04/29/2008
NPUB
NOTICE OF PUBLICATION
04/09/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/24/2008
ALIE
ASSIGNED TO LIE
03/17/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2008
RFNT
REFUSAL PROCESSED BY IB
02/15/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/14/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2008
RFRR
REFUSAL PROCESSED BY MPU
01/22/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/19/2008
CNRT
NON-FINAL ACTION WRITTEN
01/18/2008
DOCK
ASSIGNED TO EXAMINER
01/09/2008
NWAP
NEW APPLICATION ENTERED
10/26/2007
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/25/2007
Continuous trademark protection
Get notified about every new filing that threatens M ET P or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.